[Federal Register Volume 66, Number 44 (Tuesday, March 6, 2001)]
[Notices]
[Pages 13544-13545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5462]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No.  99N-1075]


Public Health Impact of Vibrio Parahaemolyticus in Raw Molluscan 
Shellfish; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
meeting on: Vibrio parahaemolyticus in raw molluscan shellfish and 
human health. The purpose of the meeting is to receive comments on the 
technical aspects of the draft risk assessment on the relationship 
between Vibrio parahaemolyticus in raw molluscan

[[Page 13545]]

shellfish and human health. Notice of availability of the draft risk 
assessment was previously published in the Federal Register of January 
19, 2001.
    Date and Time: The meeting will be held on March 20, 2001, 9 a.m. 
to 3 p.m.
    Location: The meeting will be held at the Hilton Hotel-Crystal 
City, 2399 Jefferson Davis Hwy., Arlington, VA 22202.
    Contact: Catherine M. DeRoever, Center for Food Safety and Applied 
Nutrition (HFS-6), Food and Drug Administration, 200 C St. SW., 
Washington, DC 20204, 202-205-251, FAX 202-205-4970, e-mail 
<a href="/cdn-cgi/l/email-protection#c2a1a6a7b0ada7b4a782a1a4b1a3aceca4a6a3eca5adb4"><span class="__cf_email__" data-cfemail="f5969190879a908390b5969386949bdb939194db929a83">[email protected]</span></a>.
    Agenda: FDA is seeking comments on the draft risk assessment in the 
following areas: (1) The assumptions made, (2) the modeling technique, 
(3) the data used, and (4) the transparency of the draft risk 
assessment document. FDA will review and evaluate all public comments 
and make modifications to the risk assessment, as appropriate.
    Registration and Requests for Oral Presentation: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number) to the contact person by March 14, 2001. Interested persons 
may present data, information, or views orally or in writing, on the 
draft risk assessment on the relationship between V. parahaemolyticus 
in raw molluscan shellfish and human health. Written submissions must 
also be made to the contact person by March 14, 2001. Time allotted for 
each presentation may be limited. If you wish to make a formal oral 
presentation, you should notify the contact person before March 14, 
2001, and be prepared to provide a brief statement of the general 
nature of the evidence you wish to present.
    If you need special accommodations due to a disability, please 
contact Catherine M. DeRoever (address above) at least 7 days in 
advance.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

    Dated: February 28, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-5462 Filed 3-1-01; 4:23 pm]
BILLING CODE 4162-01-S


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>